Penumbra Inc (PEN) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.059x

Based on the latest financial reports, Penumbra Inc (PEN) has a cash flow conversion efficiency ratio of 0.059x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($86.97 Million) by net assets ($1.47 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See PEN net asset quality index to measure how much of total assets are equity-financed.

Penumbra Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Penumbra Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Penumbra Inc (PEN) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Penumbra Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Penumbra Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Equity Lifestyle Properties Inc
NYSE:ELS
0.107x
TransUnion
NYSE:TRU
0.017x
Canara Bank
NSE:CANBK
-1.285x
Ascendis Pharma AS
F:A71
-0.016x
Allegro.eu S.A.
WAR:ALE
0.012x
Ally Financial Inc
NYSE:ALLY
0.078x
GAIL (India) Limited
NSE:GAIL
0.065x
Aditya Birla Capital Limited
NSE:ABCAPITAL
-0.407x

Annual Cash Flow Conversion Efficiency for Penumbra Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Penumbra Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Penumbra Inc worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.43 Billion $238.66 Million 0.167x +14.20%
2024-12-31 $1.15 Billion $168.48 Million 0.146x +77.31%
2023-12-31 $1.18 Billion $97.33 Million 0.083x +248.16%
2022-12-31 $998.86 Million $-55.66 Million -0.056x -659.43%
2021-12-31 $953.93 Million $9.50 Million 0.010x +119.11%
2020-12-31 $637.79 Million $-33.24 Million -0.052x -194.97%
2019-12-31 $485.61 Million $26.65 Million 0.055x -19.52%
2018-12-31 $422.42 Million $28.81 Million 0.068x +115.17%
2017-12-31 $400.41 Million $12.69 Million 0.032x +165.97%
2016-12-31 $266.55 Million $-12.81 Million -0.048x +49.85%
2015-12-31 $232.52 Million $-22.28 Million -0.096x -118.55%
2014-12-31 $-12.37 Million $-6.39 Million 0.516x +22.61%
2013-12-31 $-8.06 Million $-3.40 Million 0.421x --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.71 Billion
Market Cap Rank
#1874 Global
#707 in USA
Share Price
$323.21
Change (1 day)
-0.31%
52-Week Range
$225.54 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more